ERBITUX - cetuximab
Navigation: NDC > Supplier starting with: I > IMCLONE LLC| Field | Value |
|---|---|
| NDC Code: | 66733-958 |
| Proprietary Name: | ERBITUX |
| Suffix: | |
| Non-Proprietary Name: | cetuximab |
| Dosage Form: | SOLUTION |
| Method: | INTRAVENOUS |
| Original Marketing Date: | 02-10-2007 |
| Category Name: | BLA |
| Application Number: | BLA125084 |
| Labeler: | IMCLONE LLC |
| Substance Name: | CETUXIMAB |
| Active Numerator Strength: | 2 |
| Active Ingredient Unit: | mg/mL |
| Pharm Classes: | Epidermal Growth Factor Receptor Antagonist [EPC],HER1 Antagonists [MoA] |
| DEA Schedule: |